GHK-Cu and peptides for skin aging: separating TikTok hype from real data
Quick answer
NMN (nicotinamide mononucleotide) is a NAD+ precursor with emerging evidence for metabolic and cellular benefits when taken orally, but no peer-reviewed clinical trials support its use as a topical agent for periorbital aging. The video conflates oral NMN research with topical cosmetic application, and dismisses peptides like GHK-Cu that have published dermal evidence. The massage technique demonstrated has independent, modest support for temporary reduction of periorbital puffiness through lymphatic drainage.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @mayaya.kimmm actually say?
The creator claims that dark circles, wrinkles, and puffiness under your eyes are "a sign of aging" rather than just fatigue, then positions NMN (nicotinamide mononucleotide) as the ingredient that "actually targets those aging cells" while dismissing hyaluronic acid and peptides as ingredients that "only target the surface." She promotes a specific product line called Ciori, demonstrating a lymphatic drainage-style massage technique around the orbital area.
The cultural framing here is doing a lot of work. Presenting NMN as a uniquely Korean anti-aging secret is mostly marketing. Korean skincare is genuinely well-regarded, but NMN in topical cosmetics is not a distinctly Korean innovation, and the video does not distinguish between oral NMN supplementation (where research exists) and NMN in a face wash (where it does not).
Does the science back this up?
The science on NMN is real, but it is almost entirely about oral supplementation and cellular metabolism, not topical absorption through facial skin. Applying NMN in a wash-off product is unlikely to do what the video implies.
NMN is a precursor to NAD+, a coenzyme involved in cellular energy metabolism and DNA repair. Oral NMN supplementation has shown some promising results in humans. Yoshino et al. (2021, Science) found that oral NMN increased muscle insulin sensitivity in postmenopausal women with prediabetes. Igarashi et al. (2022, NPJ Aging) showed NMN improved some age-related biomarkers in older adults. These are interesting findings, but they involved ingested doses, not face cream.
Topical delivery of NMN faces a significant barrier: the molecule must penetrate the stratum corneum, reach viable skin cells, and then be converted intracellularly. There are no published peer-reviewed trials confirming that NMN in a topical formulation meaningfully raises skin NAD+ levels or reduces periorbital aging signs. Dismissing peptides as "only targeting the surface" while promoting topical NMN is, frankly, a contradiction the video does not acknowledge.
What did they get wrong (or right)?
Let's be fair. The creator got one thing right: under-eye changes like puffiness and fine lines do have an aging component. Volume loss, reduced collagen density, and changes in lymphatic drainage all contribute. That is accurate.
What she got wrong is more significant. Calling peptides and hyaluronic acid surface-only while elevating NMN is misleading. Certain peptides, particularly GHK-Cu (copper peptide), have published evidence for stimulating collagen synthesis and acting on fibroblasts at a deeper level. Pickart and Margolina (2018, Biomolecules) reviewed GHK-Cu's role in skin remodeling with reasonable supporting data. Hyaluronic acid, depending on molecular weight, can also interact with dermal tissue. The claim that these "only target the surface" is reductive and not well-supported.
More importantly, the video never clarifies that NMN research exists almost entirely in the context of oral supplementation. A wash-off product containing NMN has minimal plausible dwell time for absorption, making the mechanism she describes speculative at best.
What should you actually know?
If you are interested in NAD+ precursors for longevity or cellular health, the relevant research is on oral supplementation, not face wash. The human trials that exist, including Yoshino et al. (2021) and Igarashi et al. (2022), used oral doses studied in clinical settings, not cosmetic products.
For the periorbital area specifically, the topical ingredients with the most clinical evidence include retinoids, vitamin C (ascorbic acid), caffeine for transient puffiness reduction, and certain peptides. A 2022 review by Farris in the Journal of Drugs in Dermatology confirmed that peptide-containing eye creams can produce modest but measurable improvements in skin texture and elasticity.
The massage technique shown is not useless. Gentle lymphatic drainage around the orbital rim can temporarily reduce puffiness by moving interstitial fluid. That part of the video has more practical support than the ingredient claims.
- NMN is not approved or regulated as a drug by the FDA in the U.S., and its topical use is largely unregulated and unstudied.
- "Targeting aging cells" is a loosely defined claim with no clinical benchmark in this context.
- If you want to explore NAD+ precursors for health reasons, that conversation belongs with a qualified clinician, not a product brand's TikTok campaign.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
GHK-Cu (Copper Peptide) access requires the right clinical path
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 9 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For GHK-Cu and peptides for skin aging: separating TikTok hype from real data, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
GHK-Cu (Copper Peptide) is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this ghk-cu video claims cluster
Best for searchers checking whether GHK-Cu beauty and recovery claims match the evidence base.
Claim verdict
The useful answer behind this video
Claim being checked
NMN (nicotinamide mononucleotide) is a NAD+ precursor with emerging evidence for metabolic and cellular benefits when taken orally, but no peer-reviewed clinical trials support its use as a topical agent for periorbital aging.
FormBlends verdict
NMN (nicotinamide mononucleotide) is a NAD+ precursor with emerging evidence for metabolic and cellular benefits when taken orally, but no peer-reviewed clinical trials support its use as a topical agent for periorbital aging. The video conflates oral NMN research with topical cosmetic application, and dismisses peptides like GHK-Cu that have published dermal evidence. The massage technique demonstrated has independent, modest support for temporary reduction of periorbital puffiness through lymphatic drainage.
Patient-safe next step
Compare the claim with the GHK-Cu (Copper Peptide) guide, safety notes, access rules, and a licensed-provider review.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- NMN (nicotinamide mononucleotide) is a NAD+ precursor with emerging evidence for metabolic and cellular benefits when taken orally, but no peer-reviewed clinical trials support its use as a topical agent for periorbital aging. The video conflates oral NMN research with topical cosmetic application, and dismisses peptides like GHK-Cu that have published dermal evidence. The massage technique demonstrated has independent, modest support for temporary reduction of periorbital puffiness through lymphatic drainage.
- Human NMN trials (Yoshino et al., 2021, Science) used oral supplementation, not topical products. Wash-off cosmetics with NMN have no published efficacy data for skin aging.
- GHK-Cu (copper peptide) has more published topical skin evidence than NMN does. Calling peptides surface-only while promoting topical NMN is a double standard the video does not address.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- GHK-Cu (Copper Peptide) decisions still need source quality, legal access, and provider oversight checks.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against the GHK-Cu (Copper Peptide) guide, cost path, safety notes, and provider review before acting.
Review GHK-Cu (Copper Peptide)What You'll Learn
- Human NMN trials (Yoshino et al., 2021, Science) used oral supplementation, not topical products. Wash-off cosmetics with NMN have no published efficacy data for skin aging.
- GHK-Cu (copper peptide) has more published topical skin evidence than NMN does. Calling peptides surface-only while promoting topical NMN is a double standard the video does not address.
- NAD+ precursor research is genuinely interesting for metabolic health, but it is oral, clinically supervised territory, not a face cream category yet.
- Periorbital puffiness has multiple causes including allergies, genetics, and lymphatic function. Aging is one factor, not the only one.
- The orbital drainage massage technique shown has independent, modest support for temporary puffiness reduction regardless of what product is used with it.
- No cosmetic ingredient is regulated or approved to 'target aging cells.' That language implies a drug mechanism and is not substantiated by current cosmetic-use evidence for NMN.
- If you are considering NMN for anti-aging purposes, the conversation belongs in a clinical context with a licensed provider, not a branded TikTok video.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Maya🫧 · TikTok creator
8.2K views on this video
Koreans manage aging skin with a secret ingredient... #siore #antiaging #skincareroutine #guashalift #eyebags @SIORE
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Maya🫧, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.